Campbell & Co Investment Adviser’s Dr. Reddy's Laboratories RDY Stock Holding History

Campbell & Co Investment Adviser’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-49,017	Closed	-$685K	–	1361
2025 Q3	$685K	Sell	49,017 -96,860	-66%	-$1.39M	0.05%	582
2025 Q2	$2.19M	Buy	+145,877	New	+$2.08M	0.14%	226
2024 Q4	–	Sell	-55,130	Closed	-$876K	–	1309
2024 Q3	$876K	Buy	55,130 +38,215	+226%	+$615K	0.07%	484
2024 Q2	$258K	Sell	16,915 -22,735	-57%	-$326K	0.02%	888
2024 Q1	$582K	Buy	+39,650	New	+$579K	0.05%	631
2023 Q4	–	Sell	-65,245	Closed	-$873K	–	1297
2023 Q3	$873K	Buy	+65,245	New	+$883K	0.1%	314
2022 Q2	–	Sell	-18,610	Closed	-$207K	–	876
2022 Q1	$207K	Buy	+18,610	New	+$211K	0.06%	622
2020 Q3	–	Sell	-19,725	Closed	-$209K	–	462
2020 Q2	$209K	Buy	+19,725	New	+$201K	0.26%	207
2018 Q3	–	Sell	-62,645	Closed	-$403K	–	504
2018 Q2	$403K	Buy	+62,645	New	+$395K	0.31%	107
2018 Q1	–	Sell	-43,185	Closed	-$324K	–	507
2017 Q4	$324K	Buy	+43,185	New	+$311K	0.24%	159
2013 Q4	–	Sell	-162,105	Closed	-$1.23M	–	292
2013 Q3	$1.23M	Buy	+162,105	New	+$1.18M	0.24%	125

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Campbell & Co Investment Adviser's RDY Position: Q4 2025 in Review

Campbell & Co Investment Adviser sold out of Dr. Reddy's Laboratories (RDY) in Q4 2025, closing a stake of 49,017 shares — an estimated $685K sold.

Campbell & Co Investment Adviser first reported a position in RDY in Q3 2013 and held it in 11 quarters. The position peaked at $2.19M in Q2 2025. 236 funds tracked by Wall St. Rank hold RDY as of Q4 2025.

Campbell & Co Investment Adviser reported no remaining Dr. Reddy's Laboratories position as of Q4 2025 after selling out during the quarter.
Campbell & Co Investment Adviser sold 49,017 Dr. Reddy's Laboratories shares in Q4 2025, an estimated $685K.
Campbell & Co Investment Adviser first reported a position in Dr. Reddy's Laboratories in Q3 2013 and held it in 11 quarters.
Campbell & Co Investment Adviser's Dr. Reddy's Laboratories position peaked at $2.19M in Q2 2025.
236 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2025, filed 12 Feb 2026.